NCT03225352 - A Study to Assess Disintegration of the New Aspirin Disintegrating Tablets | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 7, 2017

Primary Completion Date

October 7, 2017

Study Completion Date

October 16, 2017

Conditions

Moderate Pain

Interventions

DRUG

500 mg acetylsalicylic acid (Aspirin, BAYE4465)

Single intake of 1 tablet, 500mg

DRUG

1000 mg acetylsalicylic acid (Aspirin, BAYE4465)

Single intake of 1 tablet, 1000mg

DRUG

400 mg ibuprofen(Nurofen)

Single intake of 1 tablet, 400mg

DRUG

400 mg ibuprofen (Dolormin Extra)

Single intake of 1 tablet, 400mg

Trial Locations (1)

Bio-Images Research Ltd, Glasgow